Planning design of locally advanced pancreatic carcinoma using 4DCT and IMRT/IGRT technologies
暂无分享,去创建一个
Valentino Bettinardi | Riccardo Calandrino | Sara Broggi | Paolo Passoni | Giovanni M Cattaneo | Nadia Di Muzio | V. Bettinardi | M. Reni | G. Cattaneo | R. Calandrino | S. Broggi | P. Passoni | Michele Reni | Najla Slim | N. Muzio | Giulia Sangalli | N. Slim | G. Sangalli
[1] F. Fazio,et al. Evidence of limited motion of the prostate by carefully emptying the rectum as assessed by daily MVCT image guidance with helical tomotherapy. , 2008, International journal of radiation oncology, biology, physics.
[2] Elisabetta Cagni,et al. Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[3] Quynh-Thu Le,et al. Non-small cell lung cancer: Clinical practice guidelines in oncology , 2006 .
[4] Suresh Senan,et al. Evaluation of four-dimensional computed tomography-based intensity-modulated and respiratory-gated radiotherapy techniques for pancreatic carcinoma. , 2008, International journal of radiation oncology, biology, physics.
[5] E. Touboul,et al. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] Steve B. Jiang,et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. , 2006, Medical physics.
[7] Li Zhang,et al. Defining internal target volume (ITV) for hepatocellular carcinoma using four-dimensional CT. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[8] P. Philip,et al. A Multi-Institutional Phase II Trial of Preoperative Full-Dose Gemcitabine and Concurrent Radiation for Patients With Potentially Resectable Pancreatic Carcinoma , 2006, Annals of Surgical Oncology.
[9] Seong Soo Shin,et al. Differences in abdominal organ movement between supine and prone positions measured using four-dimensional computed tomography. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[10] Steve B. Jiang,et al. The management of respiratory motion in radiation oncology report of AAPM Task Group 76. , 2006, Medical physics.
[11] Riccardo Calandrino,et al. Intensity-modulated proton therapy versus helical tomotherapy in nasopharynx cancer: planning comparison and NTCP evaluation. , 2008, International journal of radiation oncology, biology, physics.
[12] Pietro Mancosu,et al. Contrast enhanced 4D-CT imaging for target volume definition in pancreatic ductal adenocarcinoma. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] M. Reni,et al. Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial. , 2005, The Lancet. Oncology.
[14] J. Roeske,et al. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. , 2004, International journal of radiation oncology, biology, physics.
[15] D. Gouma,et al. Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma , 2000, Cancer.
[16] M. Goitein,et al. Tolerance of normal tissue to therapeutic irradiation. , 1991, International journal of radiation oncology, biology, physics.
[17] K. Camphausen,et al. A dosimetric analysis of dose escalation using two intensity-modulated radiation therapy techniques in locally advanced pancreatic carcinoma. , 2006, International journal of radiation oncology, biology, physics.
[18] B Sanchez-Nieto,et al. BIOPLAN: software for the biological evaluation of. Radiotherapy treatment plans. , 2000, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.
[19] R. Ove,et al. Locally advanced pancreatic cancer: a review. , 2007, Seminars in oncology.
[20] J. Bogart,et al. Hypofractionated irradiation for non-small cell lung cancer. , 2002, Lung cancer.
[21] Douglas B. Evans,et al. Future chemoradiation strategies in pancreatic cancer. , 2007, Seminars in oncology.
[22] F. Fazio,et al. Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[23] M. Goitein,et al. Fitting of normal tissue tolerance data to an analytic function. , 1991, International journal of radiation oncology, biology, physics.
[24] Jay Burmeister,et al. Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer. , 2004, International journal of radiation oncology, biology, physics.
[25] K. Vineberg,et al. Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions. , 2007, Medical physics.
[26] John D Fenwick,et al. A challenge to traditional radiation oncology. , 2004, International journal of radiation oncology, biology, physics.
[27] X Sharon Qi,et al. Interfractional variations in patient setup and anatomic change assessed by daily computed tomography. , 2007, International journal of radiation oncology, biology, physics.
[28] Edgar Ben-Josef,et al. Full-dose gemcitabine and concurrent radiotherapy for unresectable pancreatic cancer. , 2007, International journal of radiation oncology, biology, physics.